You are ready to start your business, however, is the University or Medical Center ready as well to let go of the ‘invention’? Many academic institutions take equity in lieu of cash when they license their technologies to startup companies. Others require university inventors to assign the rights to their inventions to the university. The inventor who wants to use the technology to start a company has to license it from the institution? What does it take to spin-off?
Gain Knowledge and make new Connections
- Expert Class Features: Startup case | Expert lecture | Workshop |TTOs | Partnering | Networking
- Download the final and detailed programme >
- Experts: Cristianne Rijcken (Cristal Therapeutics) | Oscar Schoots (UMCU) | Wietse Mulder (GenDx) | Hamza Zourakhti (Loyens & Loeff) and TTOs from Oncode Institute, Erasmus MC, Amsterdam UMC
- Info and registration: Send an email to Ellen de Waal >
- Date/Time: Friday, 5 July 2019 | 11:00 – 17:00 hrs
- Venue: UMC Utrecht, Descartes-Centrum, 11th floor, Matthias van Geunsgebouw, Bolognalaan 48, 3584 CJ Utrecht. Download how to get there (in Dutch) >
Programme | Download the final and detailed programme >
Starting up Cristal Therapeutics
Cristianne Rijcken, Founder and CSO.
Cristal Therapeutics was founded in 2011 as a spin-off of the Department of Pharmaceutical Sciences of the Utrecht University.
Spinning off Cristal Therapeutics
Oscar Schoots, Director and former intellectual property manager Utrecht Holdings/ UMC Utrecht.
Utrecht Holdings is the Knowledge Transfer Office (KTO) of Utrecht University and University Medical Center Utrecht.
The best off ‘making deals for GenDx and KimerDx’
Wietse Mulder, CEO, GenDx
GenDx develops and markets a comprehensive line of In Vitro Diagnostic (IVD) tests. KimerDx BV was founded in 2013, winner of Venture Challenge Fall 2013, activities transferred to GenDx in 2018
Know your legal position when negotiating your invention
Attorney at law, Associate, Loyens & Loeff
Loyens & Loeff: the largest healthcare practice in the Netherlands with in-depth knowledge of events and trends in the (healthcare) sub-sectors.
Starting up from ……
Insight provided by Business Developers from Oncode Institute, Erasmus MC and AMC
Contributing organizations LS@W Expert Class 5 July 2019
LifeSciences@Work Expert classes are a series of targeted workshops organized in close collaboration with industry experts on relevant topics for Life Sciences and Medical Technologies Startups. These small-scale Expert Classes are specially organized for alumni and participants of the Venture Challenge, Value Centre, MedtechPartners, BiotechPartner and Take off and are free of charge. Startups not (yet) part of our LS@W community but who are interested to join are welcome provided you match our community profile. Check out the experts and contributing organizations from previous editions >
We thank our 2017/2018/2019 contributing Experts from Loyens & Loeff, Progress EXS, Radboud UMC, PivotPark, 3DPharmXchange, Amgen, Xeltis, Innovation Exchange Amsterdam (IXA), Amsterdam UMC – University of Amsterdam, CbusineZ, Agendia, Sanofi, YesDelft, TU Delft/Delft Enterprises, NLO, European Patent and Trademark Attorneys, DSM Global Business Incubator, TU/E Innovation Lab, Usono, Philips, M Ventures, RVO, Merck Ventures, 2-BBB, Aglaia BioMedical Ventures, Netherlands Enterprise Agency (RVO), BioGeneration Ventures, Kite Pharma EU, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Axon, eNovITe, Thuja Capital, Technology Transfer Office, Erasmus MC, European Patent Office, InnovationQuarter, Luris, BioPartner Leiden, PSR Orphan Experts, Paul Janssen Futurelab Leiden, Utrecht Holding, MDxHealth, Julius Center THINC, UMC Utrecht, Vereniging Innovatieve Geneesmiddelen, UMotion, Sciences Affairs.